ANI Pharmaceuticals has paid $17.25 million to buy out royalty obligations for ILUVIEN and YUTIQ, enhancing financial flexibility. ANI Pharmaceuticals incurred a one-time payment of $17.25 million to ...
PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results